Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enanta Pharmaceuticals (ENTA) Tax Provisions: 2014-2025

Historic Tax Provisions for Enanta Pharmaceuticals (ENTA) over the last 12 years, with Sep 2025 value amounting to -$1.8 million.

  • Enanta Pharmaceuticals' Tax Provisions rose 85.61% to -$80,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.8 million, marking a year-over-year increase of 8.47%. This contributed to the annual value of -$1.8 million for FY2025, which is 8.47% up from last year.
  • As of FY2025, Enanta Pharmaceuticals' Tax Provisions stood at -$1.8 million, which was up 8.47% from -$1.9 million recorded in FY2024.
  • Over the past 5 years, Enanta Pharmaceuticals' Tax Provisions peaked at $2.8 million during FY2023, and registered a low of -$28.7 million during FY2021.
  • Moreover, its 3-year median value for Tax Provisions was -$1.8 million (2025), whereas its average is -$295,667.
  • Per our database at Business Quant, Enanta Pharmaceuticals' Tax Provisions tumbled by 238.25% in 2021 and then surged by 728.29% in 2023.
  • Over the past 5 years, Enanta Pharmaceuticals' Tax Provisions (Yearly) stood at -$28.7 million in 2021, then spiked by 98.44% to -$449,000 in 2022, then surged by 728.29% to $2.8 million in 2023, then plummeted by 168.63% to -$1.9 million in 2024, then increased by 8.47% to -$1.8 million in 2025.